In order to inform prevention programming, we analyzed HIV discordance and concordance within couples in the Kenya AIDS Indicator Survey (KAIS) 2007.
KAIS was a nationally representative population-based sero-survey that examined demographic and behavioral indicators and serologic testing for HIV, HSV-2, syphilis, and CD4 cell counts in 15,853 consenting adults aged 15–64 years. We analyzed interview and blood testing data at the sexual partnership level from married or cohabitating couples. Multivariable regression models were used to identify factors independently associated with HIV discordant and concordant status.
Of 3256 couples identified in the survey, 2748 (84.4%) had interview and blood testing data. Overall, 3.8% of couples were concordantly infected with HIV, and in 5.8% one partner was infected, translating to 338,000 discordant couples in Kenya. In 83.6% of HIV-infected Kenyans living in married or cohabitating couples neither partner knew their HIV status. Factors independently associated with HIV-discordance included young age in women (AOR 1.5, 95% CI: 1.2–1.8; p<0.0001), increasing number of lifetime sexual partners in women (AOR 1.5, 95% CI: 1.3–1.8; p<0.0001), HSV-2 infection in either or both partners (AOR 4.1, 95% CI: 2.3–7.2; p<0.0001), and lack of male circumcision (AOR 1.6, 95% CI: 1.0–2.5; p = 0.032). Independent factors for HIV-concordance included HSV-2 infection in both partners (AOR 6.5, 95% CI: 2.3–18.7; p = 0.001) and lack of male circumcision (AOR 1.8, 95% CI: 1.0–3.3; p = 0.043).
Couple prevention interventions should begin early in relationships and include mutual knowledge of HIV status, reduction of outside sexual partners, and promotion of male circumcision among HIV-uninfected men. Mechanisms for effective prevention or suppression of HSV-2 infection are also needed.
Citation: Kaiser R, Bunnell R, Hightower A, Kim AA, Cherutich P, Mwangi M, et al. (2011) Factors Associated with HIV Infection in Married or Cohabitating Couples in Kenya: Results from a Nationally Representative Study. PLoS ONE 6(3): e17842. https://doi.org/10.1371/journal.pone.0017842
Editor: Shuang-yong Xu, New England Biolabs, Inc., United States of America
Received: November 27, 2010; Accepted: February 15, 2011; Published: March 15, 2011
This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
Funding: This study was funded through the United States President's Emergency Plan for AIDS Relief, through the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services. Several authors are employees of CDC and contributed to study design, data collection and analysis, decision to publish, and preparation of the manuscript.
Competing interests: The corresponding author declares, on behalf of all authors, that there are no financial, personal, or professional interests that could be construed to have influenced the paper. The study has not been funded or sponsored by industry. Also, the article has not been written by a professional medical writer. The authors have declared that no competing interests exist.
Sub-Saharan Africa has the highest prevalence and incidence of HIV infection worldwide, mostly attributable to heterosexual transmission . In Africa, there is increasing evidence that a large proportion of new HIV infections occur in cohabitating couples , , many of whom are unaware of both partners' sero-status , . In East Africa, 40–50% of married or cohabitating HIV-infected persons are in an HIV-discordant partnership . In Kenya, Uganda and Malawi, over 80% of all unprotected sex acts by HIV-infected persons occur with spouses or cohabitating partners , . Consequently, a high proportion of incident HIV infections occur within married or cohabitating heterosexual couples, e.g., in Uganda 65% (2004–5)  and in Zambia (2001–2) and Rwanda, an estimated 52–93% (2005) .
HIV transmission in couples has been associated with high HIV viral load , lack of male circumcision , extramarital sex , low literacy , ignorance of self or partner's HIV status , limited understanding that HIV discordance can exist within couples , and other sexually transmitted infections , . Transmission among couples has been reduced by 80% with effective interventions, including couple-specific counseling and testing and condom provision . In addition, modeling suggests that HIV transmission in heterosexual partnerships is reduced by antiretroviral treatment (ART) , and there are a number of observational studies that have shown this empirically , . However, little information is available on the risk factors for HIV transmission among couples on a national level.
We analyzed couples data from a nationally-representative, population-based survey conducted in Kenya in 2007 that included self-reported data on demographics, sexual behaviors, male circumcision, previous HIV testing, HIV status, ART use, and laboratory testing results for HIV, herpes simplex virus type 2 (HSV-2), syphilis, and CD4 counts for HIV-infected respondents. To help inform prevention interventions, we assessed independent factors associated with HIV discordance compared to HIV-uninfected couples and associated with HIV-infected concordance compared to HIV discordant couples.
Participants provided separate informed oral consent for interviews, blood draws and blood storage. Survey protocols were approved by the Ethics Review Committee of the Kenya Medical Research Institute (KEMRI) and the Institutional Review Board of the U.S. Centers for Disease Control and Prevention (CDC).
The Kenya AIDS Indicator Survey (KAIS) was a nationally representative, population-based household survey involving persons aged 15–64 years. The design for KAIS was a stratified, two-stage cluster sample that was for comparable with the design of the 2003 Kenya Demographic and Health Survey (DHS). The first stage involved selecting clusters from the same sampling frame that was used for the 2003 DHS, based on the 1999 national census, and the second stage involved the selection of households per cluster with equal probability of selection in the rural-urban strata within each district. A total of 29 field teams, each consisting of six data collectors (four interviewers and two laboratory technicians), one supervisor and one driver, conducted fieldwork from August to December 2007. Teams administered questionnaires in local languages where necessary, in addition to questionnaires in Kiswahili and English, to accommodate respondents that were not conversant in vernacular languages. All questionnaires were back translated into English. Survey personnel participated in intensive two week training in KAIS procedures. All questionnaire responses were double-entered using Census and Survey Processing System (CSPro) version 3.3 (U.S. Census Bureau. Washington DC, USA). A series of internal consistency and range checks helped to identify any illogical responses and to verify that responses adhered to skip patterns in the questionnaire. Demographic and HIV/AIDS-specific indicators included HIV testing history, self-reported HIV status, and partner-specific behaviors and disclosure. Blood specimens were obtained in households for testing at the national reference laboratory in Nairobi for HIV, HSV-2 and syphilis. Individual test results were linked to individual and household questionnaires through unique identification numbers.
Vironostika HIV Uni-Form II antigen/antibody (BioMérieux Bv, Boseind, Netherlands) and Murex HIV antigen/antibody (Abbott/Murex-Biotech Ltd, Kent, UK) tests were used for HIV screening and confirmation, respectively, in a serial testing algorithm. Discordant samples were retested with the two assays and polymerase Chain Reaction (PCR) (Roche HIV DNA v 1.5) tests were conducted on all samples with two sets of discordant results. For quality control, all positive specimens and a random sample of 5% of negative specimens was retested in a different laboratory using the same testing algorithm. The Kalon HSV Type 2- specific IgG EIA was used for HSV-2 testing. This was a recombinant type 2 antigen (gG2) modified to eliminate reactivity arising from HSV type 1 infection and at the same time retaining the natural antigenic characteristics of HSV-2. For syphilis testing, the Treponema pallidum particle agglutination (TPPA) assay was used as a screening test and rapid plasma reagin (RPR) for confirmation at a dilution of 1∶1.
Couples were defined as being in a married or cohabitating partnership between the male head of household and his wife. In case of a polygamous partnership the husband and only one partner were included (n = 298 couples). A couple was considered HIV-discordant if one partner was HIV-infected and the other partner HIV-uninfected in HIV testing done during the study. A couple was considered to be concordantly uninfected if neither partner was HIV-infected and considered concordantly HIV-infected if both partners were HIV-infected. Couples were considered HIV-affected when they were either HIV-discordant or -concordant. We developed 2 different models to assess factors associated with couple status – one for HIV discordance as the outcome and a second one with HIV concordance as the binary outcome. In the first model, concordant HIV-infected couples were excluded from the denominator and in the second model concordant uninfected couples were excluded from the denominator. Predictor variables included socio-demographic characteristics, age difference between partners, length of relationship in years, male circumcision, syphilis, HSV-2, CD4 cell count, perception of HIV risk, outside partners, consistent condom use with outside partner in the last 12 months, number of lifetime sexual partners, and desire to have a child within next two years among women. All predictor variables were self-reported except for CD4 cell count of infected partners, HSV-2 and syphilis status. Male circumcision was based on self-report as physical examinations were not conducted. Correct knowledge of HIV status was defined as self-reported HIV status validated by laboratory testing during the study. Low perception of HIV risk was defined as small or no self-reported risk for HIV.
We performed all analyses in SAS version 9.1 (SAS Institute Inc., Cary, North Carolina, USA). Using multivariable logistic regression (SAS Survey Logistic), we calculated adjusted odds ratios (AOR) and 95% confidence intervals (CI) to identify variables associated independently with each primary outcome. Variables that were statistically significant at a 0.05 p-value level in bivariate analyses were selected for the final multivariable model by use of backwards elimination if they did not remain significant. Two way interactions between variables were considered. Confidence intervals for percentages were computed. Logistic regression was used to assess whether the probability of having a relationship of 20 years or more was related to knowledge of status and disclosure. Analyses accounted for the stratified cluster design of the survey. Each response was weighted to account for its sampling probability and to adjust for non-response rates. National estimates of numbers of concordant positive and discordant positive couples were derived by multiplying the estimated national population aged 15–64 years (19,319,000) by the estimated proportion of this group that was married/cohabitating based on survey results (0.604), then dividing by 2 to get the number of couples and finally multiplying that result by the estimated proportion of couples that were discordant (0.058) or concordant positive (0.038). Correct knowledge and disclosure of HIV status were not included in the models because of uncertainty of the cause-effect relationship in a cross-sectional study and because of our inability to construct a variable by HIV status to measure the prevention effect in the infected discordant partner. We also decided not to include condom use between married or cohabitating partners in the models because we were not able to adjust for correct knowledge and disclosure of HIV infection status. Widow-hood was not included in models because this information was not available for men and numbers were too small for women.
A total of 9,049 women and 6,804 men aged 15–64 years living in 9,691 households from 402 clusters participated in both interviews and blood sample collection. This included 2,748 married or cohabitating couples. The response rate for couples was 84.4% (Figure 1). Overall, 9.6% (95% CI: 8.3–10.9) of couples were affected by HIV; 3.8% (95% CI: 3.0–4.5) were concordantly infected and 5.8% discordantly infected (95% CI: 4.7–6.8). In 48.5% (95% CI: 40.3–56.5) of discordant couples the woman was the HIV-infected partner. Extrapolating to population estimates, this corresponds to an estimated 219,000 concordant infected couples and 338,000 discordant couples in Kenya. Of all couples, 30.4% (95% CI: 28.3–32.5) were concordantly positive for HSV-2 and 20.7% (95% CI: 18.9–22.5) were HSV-2 discordant.
Among all married or cohabitating HIV-infected Kenyans, 42.8% (95% CI: 36.5–49.0) had a previous HIV test and 16.4% (95% CI: 11.5–20.8) knew their HIV status correctly. Among the 83.6% HIV-infected Kenyans living in a couple who did not know their status correctly, 24.8% (95% CI: 20.1–29.6) self-reported that they were HIV-uninfected based on their most recent test results, and 57.2% (95% CI: 51.0–63.5) never had an HIV test or received their test result. Only 14.9% (95% CI: 10.4–19.4%) of HIV-infected Kenyans living in a couple correctly knew their status and also reported that they disclosed to their partner; however, this meant that most disclosed when they knew their status. Among discordant couples, in 5.5% (95% CI: 1.7–9.3) both partners correctly knew their status and disclosed their status to the partner. In 31.8% of discordant couples the infected partner reported being HIV-uninfected based on a prior test. In infected concordant couples, 16.2% (95% CI: 10.0–22.4) correctly knew their status and disclosed their status to the partner. In 34.7% (95% CI: 26.5–42.9) of concordant couples at least one partner had a prior HIV-negative test and was unaware of his or her current HIV infection. Partnerships of 20 years or more duration were reported by 38.3% (95% CI: 29.3–47.3) of discordant and 28.4% (95% CI: 18.6–38.2) of concordant couples. Among those, rates of correct knowledge of status and disclosure were not significantly different than among couples with relationships of less than 20 years. In 3.2% uninfected (95% CI: 2.4–5.0), 6.6% discordant (95% CI: 2.5–10.6) and 16.3% concordant (95% CI: 9.2–23.5) infected couples one or both partners reported consistent condom use in the last 12 months.
Table 1 shows characteristics of married or cohabitating couples for predictor variables included in bivariate analyses. Proportions of HIV-affected couples were highest in the 15–24 years age categories for both female (4.1%, 95% CI: 1.9%–6.4%) and male (4.3%, 95% CI: 1.8%–6.9%) HIV-infected partners. Furthermore, the proportions of HIV-affected couples were highest in Nyanza (21.8%, 95% CI: 17.3%–26.4%) and lowest in North Eastern (2.8%, 95% CI: 0%–5.8%) (Table 1), the provinces with the highest and lowest HIV prevalence rates (14.9% and 0.8%, respectively ).
Factors associated with discordance
Table 2 shows results of bivariate and multivariable analyses for variables associated with HIV discordance compared to HIV uninfected concordance. In final multivariable models, predictors for HIV-discordance included younger age in women (AOR 1.5, 95% CI: 1.2–1.8 per 10 years; p<0.0001), increasing number of lifetime sexual partners in women (AOR 1.5, 95% CI: 1.3–1.8; p<0.0001), HSV-2 infection in either (man infected: AOR 3.1, 95% CI: 1.6–6.3; p = 0.001; woman infected: AOR 3.5, 95% CI: 1.9–6.4; p<0.0001) or both partners (AOR 4.1, 95% CI: 2.3–7.2; p<0.0001), and lack of male circumcision (AOR 1.6, 95% CI: 1.0–2.5; p = 0.032) (Table 2).
Factors associated with concordance
Table 3 shows results of bivariate and multivariable analyses for variables associated with HIV concordance compared to HIV discordance. In final multivariable models, independent factors for HIV-concordance included HSV-2 infection in both partners (AOR 6.5, 95% CI: 2.3–18.7; p = 0.001) and lack of male circumcision (AOR 1.8, 95% CI: 1.0–3.3; p = 0.043) (Table 3).
No significant interactions were found in the models. Also, in both models there were too few people in partnerships with CD4 cell counts to use it as a proxy for length of infection or on ART to compute the effect of ART with any degree of confidence (e.g. there were 153 discordant couples with one partner on ART and available CD4 counts; of those, 24 had a CD4 count less than 250 cells/µl).
In a nationally representative sample of Kenyans aged 15–64, 1 in 10 married or cohabitating couples was affected by HIV. Regional variations were pronounced, with the highest proportion of couples in Nyanza province being HIV-affected and the lowest in North Eastern province. Nyanza province is located on the shore of Lake Victoria in the tropical part of Kenya with the highest rates for HIV and other infectious diseases in the country while North Eastern province is mostly arid and less populated. Younger age in women, an increasing number of lifetime partners in women, HSV-2 infection in one or both partners, and lack of circumcision in the male partner were associated with HIV infection in discordant couples compared with uninfected couples in multivariable analyses. Our findings suggest a scenario where young women may enter a marriage or cohabitation when they are already HIV-infected or HIV/HSV-2 –co-infected, especially if women have multiple sexual partners early after sexual debut. Young women may also be HIV-uninfected but start the relationship with a man who is already HIV-infected or HIV/HSV-2 –co-infected.
Despite considerably less power to show significant associations, HSV-2 infection in both partners and lack of circumcision in the male partner were associated with being in a concordantly infected couple compared to a discordant couple, indicating the need to address these risk factors in prevention programs for discordant couples. Our findings were consistent with the literature , , , – and therefore confirmed previously reported associations at a national population level in Kenya.
Married or cohabitating couples are a population at high risk for HIV transmission and acquisition in Kenya. Discordant couples represent a particular high risk group. Also, partners in the acute phase of a new infection pose a high risk for onward transmission within the couple or if they have unprotected sex outside of the couple. Without intervention, 8–12% of HIV-infected adults living in couples will transmit HIV to their partners annually . If all the 338,000 uninfected partners became infected HIV prevalence in Kenya could increase by up to 2% (based on the KAIS 2007 prevalence of 7.1% ). Currently, prevention messages often ignore couples, focusing on casual partnerships despite the frequent lack of knowledge within HIV-affected couples of the risk of transmission within their partnership or through perinatal transmission. Lack of knowledge may be increased by a lack of risk awareness within a stable relationship that results in low condom use, as was confirmed in our study. The desire in female partners to have a child in the next 2 years did not remain significant as a risk factor for discordant couple status in the multivariable analysis; however, getting pregnant in a natural way requires unprotected sex, which raises the question of adequate risk counseling and family planning.
The importance of prevention interventions targeted to couples is increasingly recognized , . Interventions need to encourage couples to be tested together early in the relationship and mutually know their HIV status by learning their test result at the same time or disclosing their status to each other. Partner testing for HIV-infected persons in care and treatment programs should be standard practice as recommended by the World Health Organization . Our results indicated a considerable need for family planning counseling, which should be an integral part of all testing and counseling services. Understanding of HIV discordance, even among health providers, is limited, and common misconceptions may undermine risk reduction efforts . Both lack of male circumcision and HSV-2 infection have been shown to be associated with increased HIV transmission –. Our findings confirm that male circumcision will benefit couples by increasing the male partner's likelihood of remaining HIV uninfected. HIV testing and counseling offer an opportunity to refer uncircumcised, HIV-uninfected men for voluntary medical male circumcision. Strong associations between HSV-2 infection and both HIV discordance and concordance reinforce the need to further advance our knowledge on the role of HSV-2 as a biological cofactor in HIV acquisition and transmission  and develop policies and program guidelines for HSV-2 as a risk factor for HIV infection in couples. HSV-2 suppression with twice daily acyclovir assessed in clinical trials did not prevent HIV acquisition ,  or transmission . An antiretroviral vaginal gel has recently shown promising results in reducing HSV-2 acquisition . In addition, a HSV-2 vaccine, if it is approved, should be considered to reduce the risk of HSV-2 infection in HIV uninfected and discordant couples .
Similar proportions of couples as found in our study may be affected by HIV in other countries in Sub-Saharan Africa with a generalized HIV epidemic similar to Kenya's. The vast majority of these couples are unaware of their HIV infection and many perceive themselves to be at low risk with no need for testing. Opportunities for expanding couples testing and counseling exist in Kenya, including integration of partner testing into HIV care and treatment programs, enhanced partner testing in prevention of mother to child transmission and tuberculosis programs, and home-based HIV couples testing. Couples testing and counseling should be a central component of Kenya's national HIV prevention strategy.
Our analysis had some limitations. Cross-sectional surveys do not allow for determination of the sequence of cause and effect which complicates interpretation of associations. Because of the cross-sectional design, we were unable to include some factors associated with HIV acquisition in our models (e.g. correct knowledge of status). The way the household questionnaire was constructed only allowed including couples in which the head of household was the male partner and co-wives in polygamous partnerships could not be analyzed. Some data were not available from the study, e.g. whether respondents had tested for HIV as a couple. Finally, Kenya's population structure with over 40 ethnic tribes of considerable cultural differences may have resulted in some differences in self-reporting; however, the direction and magnitude of potential reporting bias is unknown.
The authors thank George Rutherford and Jennifer Galbraith for insightful comments on the manuscript, and the KAIS Study Group for their contribution to design of the survey and collection of the couples data set: Michael Arnold, Godfrey Baltazar, Isack Baya, John Bore, Rebecca Bunnell, Sufia Dadabhai, Helen Dale, Jared Ichwara, Allen Hightower, Tura Galgalo, Catherine Gichimu, Anthony Gichangi, Reinhard Kaiser, Timothy Kellogg, George Kichamu, Andrea Kim, Evelyn Kim, Samuel Kipruto, George K'opiyo, Ernest Makokha, Barbara Marston, Lawrence Marum, Margaret Mburu, Jonathan Mermin, Joy Mirjahangir, Rex Mpazanje, Ibrahim Mohamed, Patrick Muriithi, James Muttunga, Mary Mwangi, Carol Ngare, Raymond Nyoka, Linus Odawo, Samuel Ogola, Christopher Omolo, Tom Oluoch, Ray Shiraishi, John Wanyungu, Anthony Waruru.
Disclaimer: The content and views in this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention.
Conceived and designed the experiments: RK RB AH AAK MM TO SD PM PC NM JM. Performed the experiments: RK RB AAK PC MM TO SD PM JM. Analyzed the data: AH. Contributed reagents/materials/analysis tools: RK RB AH AAK. Wrote the paper: RK RB AH JM.
- 1. UNAIDS (2008) Report on the global AIDS epidemic 2008. Geneva, Switzerland: UNAIDS/WHO. UNAIDS2008Report on the global AIDS epidemic 2008Geneva, SwitzerlandUNAIDS/WHO
- 2. Guthrie BL, de Bruyn G, Farquhar C (2007) HIV-1-discordant couples in sub-Saharan Africa: explanations and implications for high rates of discordancy. Curr HIV Res 5: 416–429.BL GuthrieG. de BruynC. Farquhar2007HIV-1-discordant couples in sub-Saharan Africa: explanations and implications for high rates of discordancy.Curr HIV Res5416429
- 3. Dunkle KL, Stephenson R, Karita E, Chomba E, Kayitenkore K, et al. (2008) New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data. Lancet 371: 2183–2191.KL DunkleR. StephensonE. KaritaE. ChombaK. Kayitenkore2008New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data.Lancet37121832191
- 4. Allen S, Tice J, van de Perre P, Serufilira A, Hudes E, et al. (1992) Effect of serotesting with counselling on condom use and seroconversion among HIV discordant couples in Africa. BMJ 304: 1605–1609.S. AllenJ. TiceP. van de PerreA. SerufiliraE. Hudes1992Effect of serotesting with counselling on condom use and seroconversion among HIV discordant couples in Africa.BMJ30416051609
- 5. Carpenter LM, Kamali A, Ruberantwari A, Malamba SS, Whitworth JA (1999) Rates of HIV-1 transmission within marriage in rural Uganda in relation to the HIV sero-status of the partners. AIDS 13: 1083–1089.LM CarpenterA. KamaliA. RuberantwariSS MalambaJA Whitworth1999Rates of HIV-1 transmission within marriage in rural Uganda in relation to the HIV sero-status of the partners.AIDS1310831089
- 6. Bunnell R, Mermin J, De Cock KM (2006) HIV Prevention for a Threatened Continent: Implementing Positive Prevention in Africa. JAMA 296: 855–858.R. BunnellJ. MerminKM De Cock2006HIV Prevention for a Threatened Continent: Implementing Positive Prevention in Africa.JAMA296855858
- 7. Anand A, Shiraishic RW, Bunnell RE, Jacobs K, Solehdinc N, et al. (2009) Knowledge of HIV status, sexual risk behaviors and contraceptive need among people living with HIV in Kenya and Malawi. AIDS 23: 1565–1573.A. AnandRW ShiraishicRE BunnellK. JacobsN. Solehdinc2009Knowledge of HIV status, sexual risk behaviors and contraceptive need among people living with HIV in Kenya and Malawi.AIDS2315651573
- 8. Bunnell R, Opio A, Musinguzi J, Kirungi W, Ekwaru P, et al. (2008) HIV transmission risk behavior among HIV-infected adults in Uganda: results of a nationally representative survey. AIDS 22: 617–624.R. BunnellA. OpioJ. MusinguziW. KirungiP. Ekwaru2008HIV transmission risk behavior among HIV-infected adults in Uganda: results of a nationally representative survey.AIDS22617624
- 9. Mermin J, Musinguzi J, Opio A, Kirungi W, Ekwaru JP, et al. (2008) Risk factors for recent HIV infection in Uganda. JAMA 300: 540–549.J. MerminJ. MusinguziA. OpioW. KirungiJP Ekwaru2008Risk factors for recent HIV infection in Uganda.JAMA300540549
- 10. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, et al. (2000) Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. NEJM 342: 921–929.TC QuinnMJ WawerN. SewankamboD. SerwaddaC. Li2000Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.NEJM342921929
- 11. Gray RH, Kiwanuka N, Quinn TC, Sewankambo NK, Serwadda D, et al. (2000) Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. AIDS 14: 2371–2381.RH GrayN. KiwanukaTC QuinnNK SewankamboD. Serwadda2000Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda.AIDS1423712381
- 12. Allen S, Serufilira A, Bogaerts J, Van de Perre P, Nsengumuremyi F, et al. (1992) Confidential HIV testing and condom promotion in Africa. Impact on HIV and gonorrhea rates. JAMA 268: 3338–3343.S. AllenA. SerufiliraJ. BogaertsP. Van de PerreF. Nsengumuremyi1992Confidential HIV testing and condom promotion in Africa. Impact on HIV and gonorrhea rates.JAMA26833383343
- 13. Olley BO, Seedat S, Gxamza F, Reuter H, Stein DJ (2005) Determinants of unprotected sex among HIV-positive patients in South Africa. AIDS Care 17: 1–9.BO OlleyS. SeedatF. GxamzaH. ReuterDJ Stein2005Determinants of unprotected sex among HIV-positive patients in South Africa.AIDS Care1719
- 14. Wawer MJ, Sewankambo NK, Serwadda D, Quinn TC, Paxton LA, et al. (1999) Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomized community trial. Rakai Project Study Group. Lancet 353: 525–535.MJ WawerNK SewankamboD. SerwaddaTC QuinnLA Paxton1999Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomized community trial. Rakai Project Study Group.Lancet353525535
- 15. Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, et al. (2006) Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 20: 73–83.EE FreemanHA WeissJR GlynnPL CrossJA Whitworth2006Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies.AIDS207383
- 16. Wilson DP, Law MG, Grulich AE, Cooper DA, Kaldor JM (2008) Relation between HIV viral load and infectiousness: a model-based analysis. Lancet 372: 314–320.DP WilsonMG LawAE GrulichDA CooperJM Kaldor2008Relation between HIV viral load and infectiousness: a model-based analysis.Lancet372314320
- 17. Attia S, Egger M, Mueller M, Zwahlen M, Lowa N (2009) Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 23: 1397–1404.S. AttiaM. EggerM. MuellerM. ZwahlenN. Lowa2009Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis.AIDS2313971404
- 18. Donnell D, Kiarie J, Thomas K, Baeten J, Lingappa J, et al. (2010) ART and risk of heterosexual HIV transmission in HIV-1 serodiscordant African couples: a multinational prospective study. D. DonnellJ. KiarieK. ThomasJ. BaetenJ. Lingappa2010ART and risk of heterosexual HIV transmission in HIV-1 serodiscordant African couples: a multinational prospective study.Conference on Retroviruses and Opportunistic Infections. San Francisco, USA. Conference on Retroviruses and Opportunistic Infections. San Francisco, USA.
- 19. NASCOP (2009) 2007 Kenya AIDS Indicator Survey: Final Report. Nairobi: National AIDS/STI Control Programme (NASCOP). NASCOP20092007 Kenya AIDS Indicator Survey: Final ReportNairobiNational AIDS/STI Control Programme (NASCOP)
- 20. Bunnell R, Cherutich P (2008) Universal HIV testing and counselling in Africa. Lancet 371: 2148–2150.R. BunnellP. Cherutich2008Universal HIV testing and counselling in Africa.Lancet37121482150
- 21. WHO (2007) Guidance on provider-initiated HIV testing and counselling in health facilities. Geneva: World Health Organization. WHO2007Guidance on provider-initiated HIV testing and counselling in health facilitiesGenevaWorld Health Organizationhttp://www.who.int/hiv/pub/vct/pitc/en/index.html. http://www.who.int/hiv/pub/vct/pitc/en/index.html.
- 22. Bunnell RE, Nassozi J, Marum E, Mubangizi J, Malamba S, et al. (2005) Living with discordance: knowledge, challenges, and prevention strategies of HIV-discordant couples in Uganda. AIDS Care 17: 999–1012.RE BunnellJ. NassoziE. MarumJ. MubangiziS. Malamba2005Living with discordance: knowledge, challenges, and prevention strategies of HIV-discordant couples in Uganda.AIDS Care179991012
- 23. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, et al. (2007) Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 369: 643–656.RC BaileyS. MosesCB ParkerK. AgotI. Maclean2007Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.Lancet369643656
- 24. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, et al. (2007) Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 369: 657–666.RH GrayG. KigoziD. SerwaddaF. MakumbiS. Watya2007Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial.Lancet369657666
- 25. Abu-Raddad LJ, Magaret AS, Celum C, Wald A, Longini IM, et al. (2008) Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. PLoS ONE 3: e2230.LJ Abu-RaddadAS MagaretC. CelumA. WaldIM Longini2008Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa.PLoS ONE3e2230
- 26. Watson-Jones D, Weiss HA, Rusizoka M, Changalucha J, Baisley K, et al. (2008) Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med 358: 1560–1571.D. Watson-JonesHA WeissM. RusizokaJ. ChangaluchaK. Baisley2008Effect of herpes simplex suppression on incidence of HIV among women in Tanzania.N Engl J Med35815601571
- 27. Celum C, Wald A, Hughes J, Sanchez J, Reid S, et al. (2008) Effect of acyclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet 371: 2109–2119.C. CelumA. WaldJ. HughesJ. SanchezS. Reid2008Effect of acyclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial.Lancet37121092119
- 28. Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, et al. (2010) Acyclovir and Transmission of HIV-1from Persons Infected with HIV-1 and HSV- 2. N Engl J Med. C. CelumA. WaldJR LingappaAS MagaretRS Wang2010Acyclovir and Transmission of HIV-1from Persons Infected with HIV-1 and HSV- 2.N Engl J Med
- 29. Baleta A (2010) Antiretroviral vaginal gel shows promise against HIV. Lancet 376: 320.A. Baleta2010Antiretroviral vaginal gel shows promise against HIV.Lancet376320
- 30. Freeman EE, White RG, Bakker R, Orroth KK, Weiss HA, et al. (2009) Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa. Vaccine 27: 940–946.EE FreemanRG WhiteR. BakkerKK OrrothHA Weiss2009Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa.Vaccine27940946